Globe Newswire reported that Acumen entered into a private placement for about USD 35.75 million of common stock priced at USD 3.3 per share. The financing was led by RA Capital Management, with participation from ADAR1 Capital Management. Acumen said it expects the private placement to close on or about March 16, 2026, subject to customary closing conditions. The shares have not been registered under the Securities Act, and Acumen said it plans to file a registration statement with the SEC to register the resale of the shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acumen Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603160630PRIMZONEFULLFEED9672329) on March 16, 2026, and is solely responsible for the information contained therein.